Gil Bar-Tur

qed is transforming scientific research with AI

DeepCure discovers transformative small molecule therapies for immune and inflammatory diseases. The company uses a chemistry platform that combines AI, physics-based tools and automated chemical synthesis to identify truly novel molecules that address unsolved challenges in drug discovery. The pipeline includes an oral STAT6 program with multiple novel scaffolds and an oral BRD4(BD2) program with the first truly selective inhibitor. DeepCure expects to start in clinical trials in 2025.

We are reshaping how apps are distributed and scaled

qed is transforming scientific research with AI

DeepCure discovers transformative small molecule therapies for immune and inflammatory diseases. The company uses a chemistry platform that combines AI, physics-based tools and automated chemical synthesis to identify truly novel molecules that address unsolved challenges in drug discovery. The pipeline includes an oral STAT6 program with multiple novel scaffolds and an oral BRD4(BD2) program with the first truly selective inhibitor. DeepCure expects to start in clinical trials in 2025.

PubPlus is a revenue attribution solution that helps publishers maximize content distribution spend, ad revenue, and user engagement. PubPlus seamlessly aggregates publishers data into one easy-to-manage platform where ad revenue is attributed to the marketing spend, leveraging valuable insights in order to maximize growth and profit. With PubPlus, publishers can easily spot and halt underperforming content distribution campaigns and scale the profitable ones in order to maximize their ROI. Our mission is to empower publishers by providing them with insights most publications generally overlook. These insights allow them to make better business decisions and resume control of their full potential audience. We are a dedicated team of professionals, constantly exploring new ways to make the most out of content. PubPlus was acquired by ClearPier in May 2022 - https://www.calcalistech.com/ctechnews/article/s1txkpiwc

CrunchMind is an online data driven publishing power house. Our great in house team of content writers and editors brainstorm content ideas day and night to engage our audience with the most relevant and interesting topics. We currently reach over 75M users a month across our network of owned and operated magazines. Powered by our proprietary data science algorithms we are able to personalize our content and user experienced to create the best online entertainment experience possible to our readers.